Fair Balance Prescription Drug Advertisement Act of 2001

Fact Sheet API

Bill Number

HR 2352

Introduced

Jun 27, 2001

Latest Action

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.

Sponsor

Cosponsors

Topics

Business income tax Commerce Consumer education Costs Deceptive advertising Drug advertising Drug industry Drugs Government Operations and Politics Government paperwork Health Income tax Tax deductions Taxation

Full Text

View Full Bill Text

Votes

Summary

Fair Balance Prescription Drug Advertisement Act of 2001 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.

Actions

Jul 16, 2001

Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Jun 27, 2001

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 27, 2001

Sponsor introductory remarks on measure. (CR E1225-1226)
Jun 27, 2001

Introduced in House

Amendments

Related Bills